HYPERION THERAPEUTICS INC 4
4 · HYPERION THERAPEUTICS INC · Filed May 8, 2015
Insider Transaction Report
Form 4
Santel Donald J
DirectorCEO & President
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−88,547$4,073,162→ 0 totalExercise: $7.31Exp: 2022-04-15→ Common Stock (88,547 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07−169→ 0 totalExercise: $327.95Exp: 2017-09-03→ Common Stock (169 underlying) - Disposition from Tender
Common Stock
2015-05-07$46.00/sh−10,164$467,544→ 0 total(indirect: By Trust) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−70,000$3,220,000→ 0 totalExercise: $25.97Exp: 2025-02-08→ Common Stock (70,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−303,133$13,944,118→ 0 totalExercise: $1.28Exp: 2019-11-02→ Common Stock (303,133 underlying) - Disposition from Tender
Common Stock
2015-05-07$46.00/sh−2,306$106,076→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−6,648$305,808→ 0 totalExercise: $4.08Exp: 2021-04-14→ Common Stock (6,648 underlying) - Disposition to Issuer
Common Stock
2015-05-07$46.00/sh−53,875$2,478,250→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−143,000$6,578,000→ 0 totalExercise: $24.46Exp: 2023-04-14→ Common Stock (143,000 underlying) - Disposition to Issuer
Common Stock
2015-05-07$46.00/sh−292,057$13,434,622→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−111,000$5,106,000→ 0 totalExercise: $26.74Exp: 2024-03-10→ Common Stock (111,000 underlying)
Footnotes (5)
- [F1]Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
- [F2]Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
- [F3]Shares that are being acquired by Horizon in the Merger.
- [F4]Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.
- [F5]Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger.